Literature DB >> 34339033

Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges.

Shobhana Talukdar1, Zenas Chang1, Boris Winterhoff1,2, Timothy K Starr3,4,5.   

Abstract

Ovarian cancer remains the leading cause of death from gynecologic malignancy in the Western world. Tumors are comprised of heterogeneous populations of various cancer, immune, and stromal cells; it is hypothesized that rare cancer stem cells within these subpopulations lead to disease recurrence and treatment resistance. Technological advances now allow for the analysis of tumor genomes and transcriptomes at the single-cell level, which provides the resolution to potentially identify these rare cancer stem cells within the larger tumor.In this chapter, we review the evolution of next-generation RNA sequencing techniques, the methodology of single-cell isolation and sequencing, sequencing data analysis, and the potential applications in ovarian cancer. We also summarize the current published work using single-cell sequencing in ovarian cancer.By utilizing this novel technique to characterize the gene expression of rare subpopulations, new targets and treatment pathways may be identified in ovarian cancer to change treatment paradigms.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Gene expression; Next generation RNA sequencing; Ovarian cancer; Rare cancer stem cells; Rare cancer subpopulations; Single cell isolation; Single cell sequencing; Treatment

Year:  2021        PMID: 34339033     DOI: 10.1007/978-3-030-73359-9_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  59 in total

Review 1.  The niche in single-cell technologies.

Authors:  Giacomo Donati
Journal:  Immunol Cell Biol       Date:  2015-12-22       Impact factor: 5.126

2.  Precision oncology: an overview.

Authors:  Levi A Garraway; Jaap Verweij; Karla V Ballman
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

Review 3.  Developing precision medicine in a global world.

Authors:  Eric H Rubin; Jeffrey D Allen; Jan A Nowak; Susan E Bates
Journal:  Clin Cancer Res       Date:  2014-03-15       Impact factor: 12.531

Review 4.  Ten years of next-generation sequencing technology.

Authors:  Erwin L van Dijk; Hélène Auger; Yan Jaszczyszyn; Claude Thermes
Journal:  Trends Genet       Date:  2014-08-06       Impact factor: 11.639

5.  Continuous changes in electroencephalographic topograms and auditory reaction time during simulated 21 ATA (atmospheres absolute) heliox saturation dives.

Authors:  K Ozawa; J Tatsuno
Journal:  Ann Physiol Anthropol       Date:  1989-10

6.  Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

Authors:  Richard W Tothill; Anna V Tinker; Joshy George; Robert Brown; Stephen B Fox; Stephen Lade; Daryl S Johnson; Melanie K Trivett; Dariush Etemadmoghadam; Bianca Locandro; Nadia Traficante; Sian Fereday; Jillian A Hung; Yoke-Eng Chiew; Izhak Haviv; Dorota Gertig; Anna DeFazio; David D L Bowtell
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

Review 7.  Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.

Authors:  Maria Schwaederle; Melissa Zhao; J Jack Lee; Alexander M Eggermont; Richard L Schilsky; John Mendelsohn; Vladimir Lazar; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 8.  Cancer Systems Biology: a peek into the future of patient care?

Authors:  Henrica M J Werner; Gordon B Mills; Prahlad T Ram
Journal:  Nat Rev Clin Oncol       Date:  2014-02-04       Impact factor: 66.675

9.  Whole-genome characterization of chemoresistant ovarian cancer.

Authors:  Ann-Marie Patch; Elizabeth L Christie; Dariush Etemadmoghadam; Dale W Garsed; Joshy George; Sian Fereday; Katia Nones; Prue Cowin; Kathryn Alsop; Peter J Bailey; Karin S Kassahn; Felicity Newell; Michael C J Quinn; Stephen Kazakoff; Kelly Quek; Charlotte Wilhelm-Benartzi; Ed Curry; Huei San Leong; Anne Hamilton; Linda Mileshkin; George Au-Yeung; Catherine Kennedy; Jillian Hung; Yoke-Eng Chiew; Paul Harnett; Michael Friedlander; Michael Quinn; Jan Pyman; Stephen Cordner; Patricia O'Brien; Jodie Leditschke; Greg Young; Kate Strachan; Paul Waring; Walid Azar; Chris Mitchell; Nadia Traficante; Joy Hendley; Heather Thorne; Mark Shackleton; David K Miller; Gisela Mir Arnau; Richard W Tothill; Timothy P Holloway; Timothy Semple; Ivon Harliwong; Craig Nourse; Ehsan Nourbakhsh; Suzanne Manning; Senel Idrisoglu; Timothy J C Bruxner; Angelika N Christ; Barsha Poudel; Oliver Holmes; Matthew Anderson; Conrad Leonard; Andrew Lonie; Nathan Hall; Scott Wood; Darrin F Taylor; Qinying Xu; J Lynn Fink; Nick Waddell; Ronny Drapkin; Euan Stronach; Hani Gabra; Robert Brown; Andrea Jewell; Shivashankar H Nagaraj; Emma Markham; Peter J Wilson; Jason Ellul; Orla McNally; Maria A Doyle; Ravikiran Vedururu; Collin Stewart; Ernst Lengyel; John V Pearson; Nicola Waddell; Anna deFazio; Sean M Grimmond; David D L Bowtell
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

10.  Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing.

Authors:  Jung-Yun Lee; Jung-Ki Yoon; Boyun Kim; Soochi Kim; Min A Kim; Hyeonseob Lim; Duhee Bang; Yong-Sang Song
Journal:  BMC Cancer       Date:  2015-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.